0001209191-20-033605.txt : 20200602
0001209191-20-033605.hdr.sgml : 20200602
20200602170051
ACCESSION NUMBER: 0001209191-20-033605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200601
FILED AS OF DATE: 20200602
DATE AS OF CHANGE: 20200602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GANNON STEVEN
CENTRAL INDEX KEY: 0001643085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 20937898
MAIL ADDRESS:
STREET 1: C/O XENON PHARMACEUTICALS INC.
STREET 2: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A0
ZIP: V5G 4W8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-01
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001643085
GANNON STEVEN
200 - 3650 GILMORE WAY
BURNABY
A1
V5G 4M1
BRITISH COLUMBIA, CANADA
1
0
0
0
Stock Option (Right to Buy)
13.11
2020-06-01
4
A
0
10000
0.00
A
2030-05-31
Common Shares
10000
10000
D
One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.
/s/ Cassandra Robinson, Attorney-in-fact
2020-06-02